IDEXX Laboratories, Inc (IDXX) July 20, 2021 Stock Price, Analysis & Forecast
IDEXX Laboratories, Inc (NASDAQ: IDXX) opened the trading session on July 20, 2021, at $670.92, displaying a change of -0.0015% VS the previous close at $669.4. Within the trading session, the stock price climbed to $675.09 and declined to $663.08. Finally, the stock arranged at $669.39. Nonetheless, taking into account a distant prospect, IDEXX Laboratories, Inc reported a 52 Week Range between $347.54-$675.09.
IDEXX Laboratories, Inc's shares outstanding currently cost $85.28M, concurrently with a float of $84.43M. IDXX operates in the LIFE SCIENCES sector of the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry and has a market capitalization of $57.09B (as of July 20, 2021). It should be underlined that IDEXX Laboratories, Inc's 50-day Moving Average arranged at $615.55, while such sign as 200-day Moving Average is now $538.7.
To define the company's efficiency, let's pay attention to IDEXX Laboratories, Inc's conglomerate performance. As of today, IDXX has full-time employees. IDEXX Laboratories, Inc has generated $inf per worker Within the last fiscal year. In the meantime, IDXX's income per employee was $inf. And now, let's pay attention to the company's income report. IDEXX Laboratories, Inc's Net Income for the last fiscal year was $581.78M, while such sign as Income Before Taxes was at the level of $661.63M. IDXX's Operating Income was at the mark of $694.52M.
IDEXX Laboratories, Inc (IDXX) Earnings & Revenue
Talking about the Profitability, IDXX reached a Profit Margin of 23.6% and an Operating Margin (TTM) of 27.9%. However, when we touch the questions of management effectiveness, IDEXX Laboratories, Inc generated a Return on Equity (TTM) of 166.3% and a Return on Assets (TTM) of 23.7%. A bit more income statements might bring clarity to our overview. According to the results of the latest quarter ended March 31, 2021, IDEXX Laboratories, Inc generated Revenue (TTM) of $2.86B, reporting a Quarterly Revenue Growth of 24.2%. As for the Revenue Per Share (TTM), this indicator was at the mark of $33.48. The company's Gross Profit (TTM) was $1.57B, while according to the EBITDA report, it was estimated at $895.67M.
IDEXX Laboratories, Inc (NASDAQ: IDXX) Owners & Shares
Finally, let's take a look at the share statistics. As mentioned above, IDXX's shares outstanding now amounts to $85.28M, where Shares Short was $835,250 versus the prior month amounted to $852,230. (Short % of Float was 0.99%). And now, let's overview which kind of investors works with IDEXX Laboratories, Inc's stocks. IDXX's current ownership accounts for 87.55% institutional investors, while 0.95% of shares belong to the insiders. Also worth mentioning some indicators affecting dividends & splits. Thus, IDXX's Forward Annual Dividend Rate is currently at the mark of 0, whereas the Dividend Yield is 0%, and a Dividend Payout Ratio is 0% (Dividend Date: December 31, 1969). The company's Dividend Per Share sign thereby is $None.
IDXX Trading Performance
It's time to observe the current performance indicators for IDEXX Laboratories, Inc. IDXX's price/earnings to growth ratio during the last reported quarter was 6.81%. The company's PE Ratio stands at 86.14%, while IDXX's Beta score is 0.898. Also worth noting that IDEXX Laboratories, Inc's Diluted EPS (Earnings per Share) trailing twelve months is at the mark of 7.77. Other valuable indicators are Price To Sales Ratio (TTM), which is currently recorded at 20.27, as well as Price To Book Ratio, which amounts to 81.04.
IDEXX Laboratories, Inc Analysis & Estimates
Within the previous 9-day period, IDEXX Laboratories, Inc's Average True Range (ATR) was 11.7052, while the stock's Stochastic SlowD moving average was 73.3532%, and the SlowK moving average volumed at 73.3532%.